An Open-Label, Phase 1b study of ACP-196 in Subjects with Multiple Myeloma

  • Jana, Bagi, (PI)

    Project: Other project

    StatusFinished
    Effective start/end date10/2/1510/1/19

    Funding

    • Acerta Pharma BV: $8,538.00